Phathom Pharmaceuticals Names Basta President, CEO as Curran Resigns

Dow Jones

Apr 01, 2025

By Colin Kellaher

Phathom Pharmaceuticals said Terrie Curran has resigned as president, chief executive and a member of the board for personal reasons.

Phathom on Tuesday said Steven Basta, who most recently served as CEO of anti-infective therapies company SaNOtize, has joined the Florham Park, N.J., biopharmaceutical company as president, CEO and a director.

Phathom said Basta, 59 years old, will receive an initial annual base salary of $700,000 and an annual bonus with a target of 70% of his base pay.

The company said Curran, who joined as CEO in 2019, will receive severance benefits that include a continuation of her base salary through June 30, 2026, and a lump sum equal to her target bonus for 2025.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

April 01, 2025 08:48 ET (12:48 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2524116358"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2524116358\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2524116358?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-01 20:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524116358","market":"nz","top_or_hot":-1,"title":"Phathom Pharmaceuticals Names Basta President, CEO as Curran Resigns","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/PHAT\">Phathom Pharmaceuticals</a> said Terrie Curran has resigned as president, chief executive and a member of the board for personal reasons. \n</p>\n<p>\n  Phathom on Tuesday said Steven Basta, who most recently served as CEO of anti-infective therapies company SaNOtize, has joined the Florham Park, N.J., biopharmaceutical company as president, CEO and a director. \n</p>\n<p>\n  Phathom said Basta, 59 years old, will receive an initial annual base salary of $700,000 and an annual bonus with a target of 70% of his base pay. \n</p>\n<p>\n  The company said Curran, who joined as CEO in 2019, will receive severance benefits that include a continuation of her base salary through June 30, 2026, and a lump sum equal to her target bonus for 2025. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 01, 2025 08:48 ET (12:48 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Phathom Pharmaceuticals Names Basta President, CEO as Curran Resigns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhathom Pharmaceuticals Names Basta President, CEO as Curran Resigns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-01 20:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/PHAT\">Phathom Pharmaceuticals</a> said Terrie Curran has resigned as president, chief executive and a member of the board for personal reasons. \n</p>\n<p>\n  Phathom on Tuesday said Steven Basta, who most recently served as CEO of anti-infective therapies company SaNOtize, has joined the Florham Park, N.J., biopharmaceutical company as president, CEO and a director. \n</p>\n<p>\n  Phathom said Basta, 59 years old, will receive an initial annual base salary of $700,000 and an annual bonus with a target of 70% of his base pay. \n</p>\n<p>\n  The company said Curran, who joined as CEO in 2019, will receive severance benefits that include a continuation of her base salary through June 30, 2026, and a lump sum equal to her target bonus for 2025. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 01, 2025 08:48 ET (12:48 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2524116358","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524116358","pubTimestamp":1743511680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Phathom Pharmaceuticals said Terrie Curran has resigned as president, chief executive and a member of the board for personal reasons.Phathom on Tuesday said Steven Basta, who most recently served as CEO of anti-infective therapies company SaNOtize, has joined the Florham Park, N.J., biopharmaceutical company as president, CEO and a director.Phathom said Basta, 59 years old, will receive an initial annual base salary of $700,000 and an annual bonus with a target of 70% of his base pay.The company said Curran, who joined as CEO in 2019, will receive severance benefits that include a continuation of her base salary through June 30, 2026, and a lump sum equal to her target bonus for 2025.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","PHAT":"Phathom Pharmaceuticals"},"translate_title":"柯伦辞职后，Phathom Pharmaceuticals任命巴斯塔为总裁兼首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHAT":1},"content_text":"By Colin Kellaher \n\n\n \n\n\nPhathom Pharmaceuticals said Terrie Curran has resigned as president, chief executive and a member of the board for personal reasons. \n\n\n  Phathom on Tuesday said Steven Basta, who most recently served as CEO of anti-infective therapies company SaNOtize, has joined the Florham Park, N.J., biopharmaceutical company as president, CEO and a director. \n\n\n  Phathom said Basta, 59 years old, will receive an initial annual base salary of $700,000 and an annual bonus with a target of 70% of his base pay. \n\n\n  The company said Curran, who joined as CEO in 2019, will receive severance benefits that include a continuation of her base salary through June 30, 2026, and a lump sum equal to her target bonus for 2025. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 08:48 ET (12:48 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}